Page 3 - Biosimilars Initiative News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilars initiative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilars Initiative Today - Breaking & Trending Today

Switching From Adalimumab to a Biosimilar

Specialists in rheumatology, dermatology and gastrointestinal disease discuss the evidence on efficacy and safety on switching patient to an adalimumab biosimilar. ....

Jamiet Brogan , Kostas Botsoglou , Sophia Humphreys , Jordan Axelrad , Peter Lio , Switching Therapy , Gastrointestinal Disease ,

How Providers Can Ease Patient Anxieties When Switching to Biosimilars: Adam Colborn

Adam Colborn, JD, director of government relations for the Academy of Managed Care Pharmacy, discussed how providers can comfortably switch patients to biosimilars while minimizing anxieties, as well as the impacts prior authorization requirements can have on patient access. ....

Adam Colborn , Academy Of Managed Care Pharmacy , Managed Care Pharmacy , Boundaries With Interchangeable Biosimilars , Prior Authorization ,

Strategies to Increase Adalimumab Biosimilar Uptake in Clinical Practice

A clinical pharmacist and specialists in rheumatology, dermatology, and gastrointestinal disease share strategies in how to increase the uptake of adalimumab biosimilar among providers. ....

Kostas Botsoglou , Sophia Humphreys , Jamiet Brogan , Jordan Axelrad , Peter Lio , Uptake Of Adalimumab ,

An Overview of Health Care and Pharmaceutical Trends, 2023-2024

Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year. ....

United States , Fan Alert Network , National Sales Perspectives , Academy Of Managed Pharmacy , Health Services Utilization Index , Health Care Trends , Managed Pharmacy , Care Trends , Alert Network , Services Utilization Index , Sales Perspectives , Drug Supply Chain Security Act , Health Care Market , Pharmaceutical Market ,

Selecting Between Adalimumab Biosimilars for Your Patients

Providers in rheumatology, dermatology and gastrointestinal disease talk about how they are selecting between the various adalimumab biosimilars available for their patients. ....

Kostas Botsoglou , Sophia Humphreys , Jamiet Brogan , Jordan Axelrad , Peter Lio , Treatment Selection ,